Therefore, the Board unanimously recommends that Ramtron stockholders reject the revised offer and not tender their shares into the revised offer.
“The revised price does not alter the Board’s initial conclusion that the tender offer undervalues Ramtron’s strong long-term growth prospects, particularly considering the margin benefits to be derived from the manufacturing agreement the Company recently signed with ROHM Co., Ltd, not to mention the Company’s valuable intellectual property and F-RAM technological expertise,” said Dr. William G. Howard, Ramtron’s Chairman. “We remain committed to determining a course of action through the strategic alternatives review that will enable Ramtron stockholders to fully realize the long-term value inherent in the Company’s long-term growth prospects.”
The basis for the Board’s recommendation is set forth in an Amended Schedule 14D-9 Ramtron is filing today with the Securities and Exchange Commission (“SEC”).